Today, the U.S. Food and Drug Administration (FDA) approved LITFULO™ for severe alopecia areata, marking the second FDA-approved treatment for this disease and the first approved for children 12 years and older
Workforce
A new study led by researchers at NYU Grossman School of Medicine has revealed that certain stem cells possess the unique ability to move between growth compartments in hair follicles, but get “stuck” as people
Dermatologists who specialize in hair loss report that a key component of a topical treatment works even better when taken in small doses orally.